Skip to main navigation

About
- Company
- Leadership
- Laboratory
- Careers
Products
Applications
- Personalized Cancer Vaccines
- Biomarker Discovery
Technology
Resources
- What’s New
- Conferences
- Library
- Blog
- Contact
Investors

Press Releases

Press Releases

Year

Jun 24, 2019

Personalis Announces Closing of Initial Public Offering and Exercise in Full of Over Allotment Option

Jun 19, 2019

Personalis Prices Initial Public Offering of Common Stock

May 22, 2019

Personalis, Inc. to Provide Tumor Immunogenomic Profiling to the Parker Institute for Immunotherapy Biomarker Discovery in Clinical Trial Participants

May 20, 2019

Personalis Enters into a Research Agreement with FLX Bio to Provide Comprehensive Tumor Immunogenomics Profiling for Clinical Study

May 20, 2019

Personalis, Inc. to Present at Advances in Immuno-Oncology Congress UK 2019

Apr 23, 2019

Personalis, Inc. to Present at European NeoAG Summit 2019

Apr 02, 2019

Personalis Appoints Industry Executive Aaron Tachibana as Chief Financial Officer

Mar 31, 2019

Personalis, Inc. to Present at the American Association for Cancer Research (AACR) Annual Meeting 2019

Mar 18, 2019

Personalis, Inc. to Present at ICI-IO Combinations Summit 2019

Feb 28, 2019

Personalis, Inc. to Present at the World Immunotherapy Congress USA 2019

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 12

Print Page

RSS Feeds

Email Alerts

Contact IR

Corporate Website

© 2019 Personalis Inc. All rights reserved.